Non-Billable / Non-Specific Code
ICD-10-CM D18 is the diagnosis code for Hemangioma and lymphangioma, any site. This code falls under the section "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 â Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions are not included in D18. If the patient has both, code each condition separately:
Understanding where D18 sits in the ICD-10-CM classification helps ensure proper coding:
No, D18 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
D18 is the ICD-10-CM diagnosis code for "Hemangioma and lymphangioma, any site". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
D18 is located in Section D10-D36 â "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
D18 has 2 sub-code(s) that provide more specific detail: D18.0, D18.1.
Use D18 when the patients documented diagnosis matches "Hemangioma and lymphangioma, any site" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Hemangioma and lymphangioma, any site is D18.
No, D18 is non-billable. Use a more specific sub-code for primary diagnosis billing.
D18 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D18 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.